Levothyroxine malabsorption or pseudomalabsorption? A question in the management of refractory hypothyroidism
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Purpose: The levothyroxine absorption test (LT4AT) is an important tool for distinguishing hypothyroidism due to malabsorption from 'pseudomalabsorption' conditions. Our aim was to review our institution's LT4AT results and assess its role in the management of patients with refractory hypothyroidism. Methods: We performed a retrospective study of all patients evaluated for refractory hypothyroidism who underwent LT4AT in our tertiary center between 2014 and 2020. Its results and the impact on thyroid function management during follow-up were assessed. Results: Ten female patients were included with a mean age of 40 years (min-max: 26-62). Mean weight was 72 kg (min-max: 43-88) and baseline LT4 dosage ranged from 2.5 to 5.3 µg/kg/day. The most common causes of hypothyroidism were postsurgical in 50% (n = 5) and autoimmune in 20% (n = 2). During LT4AT, normal LT4 absorption was found in all but one individual (mean FT4 increase of 231%, min-max: 85-668). The only patient with objective LT4 absorption impairment (maximal increase of 48% by hour 5) presented also Helicobacter pylori gastritis and prior history of 'intestinal surgery' during childhood. No adverse events were reported during any of the LT4ATs. During follow-up (median 11.5 months (IQR 23)), three patients obtained euthyroidism and six had improved their hypothyroidism state. Conclusions: The LT4AT is an effective and safe way to assess refractory hypothyroidism and provides valuable information to distinguish LT4 malabsorption from 'pseudomalabsorption'. Our data suggest that most patients with suspicious LT4 malabsorption perform normally during LT4AT. This test provides relevant information for better management of patients with refractory hypothyroidism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“So, TSH measurements did not provide additional information in this levothyroxine absorption test [21].”
From Levothyroxine Absorption Test With the Daily Levothyroxine Dose in Patients With “Refractory Hypothyroidism” (2025) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
(1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-2-356 · Cited by 696
International Journal of Endocrinology and Metabolism
(2026) · Intern J Endocrinol Metab · doi:10.5812/ijem · Cited by 208
Cheen, M. H. H., Tan, Y. Z., Oh, L. F., Wee, H. L., & Thumboo, J. (2019) · International Journal of Clinical Practice · doi:10.1111/ijcp.13350 · Cited by 175
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review
Skelin, M., Lucijanić, T., Amidžić Klarić, D., Rešić, A., Bakula, M., Liberati-Čizmek, A.-M., Gharib, H., & Rahelić, D. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.005 · Cited by 133
Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report
Centanni, M., Benvenga, S., & Sachmechi, I. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-017-0706-y · Cited by 113
Pseudomalabsorption of levothyroxine
Ain, K. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470150090036 · Cited by 100
Diagnosis and treatment of levothyroxine pseudomalabsorption.
Lips, D. J., Reisen, M. V., Voigt, V., & Venekamp, W. J. R. R. (2004) · PubMed · Cited by 87
Cappelli, C., Pirola, I., Daffini, L., Formenti, A., Iacobello, C., Cristiano, A., Gandossi, E., Agabiti Rosei, E., & Castellano, M. (2016) · Thyroid · doi:10.1089/thy.2015.0422 · Cited by 80
Walker, J. N., Shillo, P., Ibbotson, V, Vincent, A., Karavitaki, N., Weetman, A. P., Wass, J. A. H., & Allahabadia, A. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-1035 · Cited by 70
New Formulations of Levothyroxine in the Treatment of Hypothyroidism: Trick or Treat?
Nagy, E. V., Perros, P., Papini, E., Katkó, M., & Hegedűs, L. D. (2020) · Thyroid · doi:10.1089/thy.2020.0515 · Cited by 70
International Journal of Clinical Practice
(2022) · International Journal of Clinical Practice · doi:10.1155/ijclp · Cited by 62
Vita, R., & Benvenga, S. (2014) · Endocrine Practice · doi:10.4158/ep13316.cr · Cited by 60
Morris, J. C. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03536.x · Cited by 59
Helicobacter pyloriinfection and drugs malabsorption
Lahner, E., Virili, C., Santaguida, M. G., Annibale, B., & Centanni, M. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10331 · Cited by 55
The levothyroxine absorption test: a four-year experience (2015-2018) at the Mayo Clinic
Gonzales, K. M., Stan, M. N., Morris, J. C., Bernet, V., & Castro, M. R. (2019) · Thyroid · doi:10.1089/thy.2019.0256 · Cited by 46
Levothyroxine absorption test to differentiate pseudomalabsorption from true malabsorption
Ghosh, S., Pramanik, S., Biswas, K., Bhattacharjee, K., Sarkar, R., Chowdhury, S., & Mukhopadhyay, P. (2020) · European Thyroid Journal · doi:10.1159/000504218 · Cited by 39
Pseudomalabsorption of Levothyroxine. A Case Report.
OGAWA, D., OTSUKA, F., MIMURA, Y., UENO, A., HASHIMOTO, H., KISHIDA, M., OGURA, T., & MAKINO, H. (2000) · Endocrine Journal · doi:10.1507/endocrj.47.45 · Cited by 36
Treatment-refractory hypothyroidism
Ramadhan, A., & Tamilia, M. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110994 · Cited by 36
Multiphasic thyrotropin responses to thyroid hormone administration in man
Spencer, C. A., LoPresti, J. S., Nicoloff, J. T., Dlott, R. S., & Schwarzbein, D. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883842 · Cited by 35
Choe, W., & Hays, M. T. (1995) · The Endocrinologist · doi:10.1097/00019616-199505000-00009 · Cited by 34
Van Wilder, N., Bravenboer, B., Herremans, S., Vanderbruggen, N., & Velkeniers, B. (2017) · European Thyroid Journal · doi:10.1159/000452489 · Cited by 31
Rapid levothyroxine absorption testing: a case series of nonadherent patients
Balla, M., Jhingan, R. M., & Rubin, D. J. (2015) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.31051 · Cited by 30
Parenteral thyroxine administration
Hays, M. T. (2007) · Thyroid · doi:10.1089/thy.2006.0283 · Cited by 27
The clinical utility of free thyroxine in oral levothyroxine absorption testing
Ching Sun, G. E., Pantalone, K. M., Faiman, C., Gupta, M., Olansky, L., & Hatipoglu, B. (2014) · Endocrine Practice · doi:10.4158/ep13487.or · Cited by 27
Pseudomalabsorption of thyroid hormones: case report and review of the literature
Livadariu, E., Valdes‐Socin, H., Burlacu, M. C., Vulpoi, C., Daly, A., & Beckers, A. M. (2007) · Annales d Endocrinologie · doi:10.1016/j.ando.2007.09.003 · Cited by 26
Srinivas, V., & Oyibo, S. O. (2010) · Endocrine Practice · doi:10.4158/ep10224.cr · Cited by 23
Clinical efficacy and pharmacokinetics of levothyroxine suppository in patients with hypothyroidism
Kashiwagura, Y., Uchida, S., Tanaka, S., Watanabe, H., Masuzawa, M., Sasaki, T., & Namiki, N. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00998 · Cited by 18
Levothyroxine absorption test results in patients with TSH elevation resistant to treatment
Yildirim Simsir, I., Soyaltin, U. E., & Ozgen, A. G. (2019) · Endocrine · doi:10.1007/s12020-019-01889-x · Cited by 16
Levothyroxine pseudo-malabsorption: testing and treatment in the outpatient setting
Rdzak, G. M., Whitman, L. M., & Inzucchi, S. E. (2018) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818771433 · Cited by 14
Goichot, B., Vinzio, S., Luca, F., Sirlin, X., Sapin, R., & Schlienger, J.-L. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02975.x · Cited by 8
Cited by
The use of levothyroxine absorption tests in clinical practice
Caron, P., & Declèves, X. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad132 · Cited by 18
Caron, P., Tudor, C., & Grunenwald, S. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf017 · Cited by 8
“So, TSH measurements did not provide additional information in this levothyroxine absorption test [21].”
Cherchir, F., Oueslati, I., Mouelhi, Y., Talbi, E., Feki, M., Yazidi, M., & Chihaoui, M. (2023) · SAGE Open Medical Case Reports · doi:10.1177/2050313x231209229 · Cited by 7
Oueslati, I., Terzi, A., Yazidi, M., Kamoun, E., Feki, M., & Chihaoui, M. (2025) · Endocrine · doi:10.1007/s12020-025-04312-w · Cited by 3
One sip of water with LT-4 supplementation—a key to euthyroidism in Hashimoto’s thyroiditis
Schnedl, W. J., Michaelis, S., Mangge, H., & Enko, D. (2024) · Endocrine · doi:10.1007/s12020-024-03829-w · Cited by 1
Metadata
- Authors
- Santos Monteiro, S., Santos, T. S., Lopes, A. M., Oliveira, J. C., Freitas, C., & Couto Carvalho, A.
- Affiliations
- Division of Endocrinology, Diabetes and Metabolism. Department of Medicine, Centro Hospitalar Universitário do Porto, Largo Professor Abel Salazar Porto, Portugal
- Centro Hospitalar do Porto (PT)
- Corresponding author
- Santos, Tiago Silva
- Venue
- Endocrine Connections
- Publisher
- Bioscientifica
- Published
- 2022-12-01
- Volume
- 11
- Issue
- 12
- ISSN
- 2049-3614 (ISSN-L)
- PMC
- PMC9716372
- OpenAlex
- W4307793717
- Cited by
- 9
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 2
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Endocrine Connections (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- refractory hypothyroidism, thyroid hormone replacement, Helicobacter pylori gastritis, postoperative hypothyroidism, autoimmune hypothyroidism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.